Clinical Trial Update: A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions [Phase 1]

View source ↗

Summary

Phase I trial evaluating the safety and preliminary activity of combining gemcitabine with nab-sirolimus in adults with advanced Leiomyosarcoma or Soft-tissue s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• nab-sirolimus (sirolimus (nanoparticle albumin-bound formulation))

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leiomyosarcoma, Soft-tissue Sarcomas | Phase 1 | Status: RECRUITING